On October 16, 2026, the federal government announced an extension of the funding agreement for rare disease research during a meeting of Canadian health ministers in Winnipeg, Manitoba.

The gathering of health ministers was convened to discuss health‑care policies and funding, and the announced extension indicates continued federal support for rare disease research.